What You Should Know: - Hitachi, U of U Health, and Regenstrief researchers partnered to develop and test a new AI method to improve personalized care for diabetes patients needing complex drug treatment. - The new AI method can now be used to help determine an optimal drug regimen for a specific patient. Hitachi, University of Utah Health, and Regenstrief Institute today announced the development of an artificial intelligence (AI) method to improve care for patients with type 2
Read More
Kidney Disease
Fresenius Health Partners, InterWell Health, and Cricket Health Announce $2.4B Merger
What You Should Know: - Cricket Health is announcing today that it will merge with Fresenius Health Partners (the value-based care arm of Fresenius), and InterWell Health, to form the nation’s premier, value-based kidney care provider with a totally new model of addressing kidney disease. The new company will operate under the InterWell Health brand and is valued at $2.4B. - Together, Fresenius Health Partners, InterWell Health, and Cricket Health will drive innovation and industry
Read More
Day 3 HIMSS Roundup: Glooko Acquires DIABNEXT, GE Healthcare/AliveCor Integration
Venture Capital, Private Equity, Mergers & Acquisitions (M&A) Activity Glooko Acquires DIABNEXT® to Expand Diabetes Offerings in France Glooko, a leading provider of remote patient monitoring and data management solutions for diabetes and related chronic conditions, today announced the acquisition of DIABNEXT, a Paris-based company whose digital health platform helps people with diabetes better manage their conditions and connects to their healthcare providers, so they can
Read More
Patient Data & Decentralized Web: The Key To A Healthier Future?
Interoperable data and IT systems in healthcare has long been an enigma - many have tried to tackle the challenge, but until now very little has changed. A truly interconnected network that brings together the infinite number of siloed systems used in healthcare services around the world, and even within the same county, has remained elusive. And so too has patient access to their own data. Considered by some as two distinct problems, however in reality the answer to both is the same: web 3.0
Read More
NANI Makes Equity Investment in Strive Health for Risk Payment
What You Should Know: - Strive Health, the national leader in value-based kidney care, and Nephrology Associates of Northern Illinois and Northern Indiana (NANI), the nation’s largest independent nephrology group, today announced a strategic partnership to jointly pursue and manage global risk payment models. - This partnership will benefit people with chronic kidney disease (CKD) and end stage kidney disease (ESKD) through a “whole patient” approach that enhances lives and communities
Read More
Dosis Expands Dosing Platform to Personalize Anemia Management
What You Should Know: - Dosis, the AI-powered precision dosing platform on a mission to transform healthcare, has announced the release of its Strategic Iron Advisor (SIA) tool, the first precision dosing tool on the market for intravenous iron. - SIA is a sub-module that works with Dosis’s existing anemia tool, Strategic Anemia Advisor (SAA), to personalize anemia management. SAA is widely used nationwide to personalize Erythropoiesis Stimulating Agents (ESA) dosing, and the SIA
Read More
Sentara Healthcare Taps Sensyne to Deploy Clinical Algorithms for CKD & CHF
What You Should Know: - Sentara Healthcare, a health system in NC and VA, just partnered with Sensyne Health to drive clinical research with ethical AI. - As part of a collaboration agreement, Sentara also becomes the first of several U.S. health systems that will partner with Sensyne to implement new clinical algorithms to support patients with CKD and CHF. The agreement will enable the ethical application of clinical AI research by Sensyne through analyzing Sentara’s patient dataset to
Read More
Cricket Health Secures $83.5M to Expand Value-Based Kidney Care Model to Health Plans
What You Should Know: - Cricket Health, a San Francisco, CA-based provider of value-based kidney care with a clinically-proven approach to managing chronic kidney disease (CKD) and end-stage kidney disease (ESKD), today announced it has raised $83.5 million in Series B funding round led by Valtruis with a strategic investment from Blue Shield of California. The round also includes existing investors Oak HC/FT and Cigna Ventures, as well as K2 HealthVentures. - This new funding will help
Read More
Will U.S. Healthcare Have The Same Success Rate With Chronic Kidney Disease As Native Americans?
For years, hypertension has dominated the healthcare field, afflicting 45 percent of all adult Americans, inducing a number of lethal complications in patients across the country. Another disease that has gained renown in the world of healthcare is diabetes, afflicting 10.5 percent of the U.S. population with its own complications. Healthcare professionals have allocated untold assets in the form of time, money, and personnel to minimize the impact such diseases pose yet the relative
Read More
Q1 2021 Health IT/Digital Health PC/VE, M&A, IPOs/ SPACs Activity
The first quarter of 2021 has been one of investor optimism as the vaccine rollout continues ahead of expectations and economic activity begins to accelerate in response. Within the Health IT industry, the already strong investment and M&A trends seen in 2020 have only accelerated. Over the course of the quarter, we observed $7 billion in private equity and venture capital investment across 158 companies. By comparison, Q1 of 2020 saw $3.2 billion and 127 investments. Health IT
Read More